Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biomaterial Scaffolds Boost Interleukin Production to Promote Wound Healing

By LabMedica International staff writers
Posted on 29 Apr 2016
The improved wound healing promoted by use of "biomaterial" scaffolds was shown to be due to activation of the immune system's T helper II pathway with a subsequent increase in production of interleukins.

Biomaterial scaffolds derived from cardiac muscle and bone extracellular matrix components help to guide regenerating tissue. More...
Investigators at Johns Hopkins University (Baltimore, MD, USA) tested how such biomaterial scaffolds interact with the immune system in damaged tissue to promote repair.

They reported in the April 15, 2016, issue of the journal Science that scaffolds induced a pro-regenerative response, characterized by an mTOR/Rictor-dependent T helper II pathway that guided interleukin-4 (IL4) – dependent macrophage polarization, which was critical for functional muscle recovery. Mice that had been genetically engineered to lack T-cells did not activate interleukin production or heal as well as normal mice.

"In previous research, we have seen different immune system responses to the same biomaterial implanted in different tissues or environments, and that got us interested in how biomaterials might stimulate the immune system to promote regeneration," said senior author Dr. Jennifer Elisseeff, professor of ophthalmology and biomedical engineering at Johns Hopkins University. "We still have a lot to learn, but this study is a step toward designing materials to elicit a beneficial immune response."

Related Links:
Johns Hopkins University


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.